

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Investigating the basis of sexual dysfunction... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-331/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-331" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Investigating the basis of sexual dysfunction during late-onset hypogonadism" />
    
            <meta name="og:title" content="F1000Research Article: Investigating the basis of sexual dysfunction during late-onset hypogonadism.">
            <meta name="og:description" content="Read the latest article version by Tharu Tharakan, Saiful Miah, Channa N. Jayasena, Suks Minhas, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="18100">
            <meta name="article-id" content="16561">
            <meta name="dc.title" content="Investigating the basis of sexual dysfunction during late-onset hypogonadism">
            <meta name="dc.description" content="Late-onset hypogonadism (LOH) is the term used to describe the decline in serum testosterone levels associated with increasing age in men above 40 years. A number of symptoms are attributed to LOH, but the most common association is that of sexual dysfunction. LOH has recently come under greater scrutiny with the widespread use of testosterone therapy, and concerns regarding the efficacy and safety of testosterone replacement therapy have been raised. In particular, the cardiovascular safety and the beneficial effects of testosterone replacement therapy on general health have been questioned. This review will give an overview of the current evidence for the relationship of LOH and male sexual dysfunction.">
            <meta name="dc.subject" content="Testosterone replacement therapy, late onset hypogonadism, androgen deprivation, andropause, Prostate cancer">
            <meta name="dc.creator" content="Tharakan, Tharu">
            <meta name="dc.creator" content="Miah, Saiful">
            <meta name="dc.creator" content="Jayasena, Channa N.">
            <meta name="dc.creator" content="Minhas, Suks">
            <meta name="dc.date" content="2019/03/25">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.16561.1">
            <meta name="dc.source" content="F1000Research 2019 8:331">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Testosterone replacement therapy">
            <meta name="prism.keyword" content="late onset hypogonadism">
            <meta name="prism.keyword" content="androgen deprivation">
            <meta name="prism.keyword" content="andropause">
            <meta name="prism.keyword" content="Prostate cancer">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/03/25">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="331">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.16561.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-331">
            <meta name="citation_title" content="Investigating the basis of sexual dysfunction during late-onset hypogonadism">
            <meta name="citation_abstract" content="Late-onset hypogonadism (LOH) is the term used to describe the decline in serum testosterone levels associated with increasing age in men above 40 years. A number of symptoms are attributed to LOH, but the most common association is that of sexual dysfunction. LOH has recently come under greater scrutiny with the widespread use of testosterone therapy, and concerns regarding the efficacy and safety of testosterone replacement therapy have been raised. In particular, the cardiovascular safety and the beneficial effects of testosterone replacement therapy on general health have been questioned. This review will give an overview of the current evidence for the relationship of LOH and male sexual dysfunction.">
            <meta name="citation_description" content="Late-onset hypogonadism (LOH) is the term used to describe the decline in serum testosterone levels associated with increasing age in men above 40 years. A number of symptoms are attributed to LOH, but the most common association is that of sexual dysfunction. LOH has recently come under greater scrutiny with the widespread use of testosterone therapy, and concerns regarding the efficacy and safety of testosterone replacement therapy have been raised. In particular, the cardiovascular safety and the beneficial effects of testosterone replacement therapy on general health have been questioned. This review will give an overview of the current evidence for the relationship of LOH and male sexual dysfunction.">
            <meta name="citation_keywords" content="Testosterone replacement therapy, late onset hypogonadism, androgen deprivation, andropause, Prostate cancer">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Tharu Tharakan">
            <meta name="citation_author_institution" content="Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK">
            <meta name="citation_author_institution" content="Section of Investigative Medicine, Department of Medicine, Imperial College London, London, UK">
            <meta name="citation_author" content="Saiful Miah">
            <meta name="citation_author_institution" content="Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK">
            <meta name="citation_author" content="Channa N. Jayasena">
            <meta name="citation_author_institution" content="Section of Investigative Medicine, Department of Medicine, Imperial College London, London, UK">
            <meta name="citation_author" content="Suks Minhas">
            <meta name="citation_author_institution" content="Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK">
            <meta name="citation_publication_date" content="2019/03/25">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="331">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.16561.1">
            <meta name="citation_firstpage" content="331">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-331/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-331.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=18100 /> <input type=hidden id=articleId name=articleId value=16561 /> <input type=hidden id=xmlUrl value="/articles/8-331/v1/xml"/> <input type=hidden id=xmlFileName value="-8-331-v1.xml"> <input type=hidden id=article_uuid value=84ecdf91-c3c3-480e-b135-9387b19ae226 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Investigating the basis of sexual dysfunction during late-onset hypogonadism"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.16561.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.16561.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-331"
  },
  "headline": "Investigating the basis of sexual dysfunction during late-onset hypogonadism",
  "datePublished": "2019-03-25T11:19:44",
  "dateModified": "2019-03-25T11:19:44",
  "author": [
    {
      "@type": "Person",
      "name": "Tharu Tharakan"
    },    {
      "@type": "Person",
      "name": "Saiful Miah"
    },    {
      "@type": "Person",
      "name": "Channa N. Jayasena"
    },    {
      "@type": "Person",
      "name": "Suks Minhas"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Late-onset hypogonadism (LOH) is the term used to describe the decline in serum testosterone levels associated with increasing age in men above 40 years. A number of symptoms are attributed to LOH, but the most common association is that of sexual dysfunction. LOH has recently come under greater scrutiny with the widespread use of testosterone therapy, and concerns regarding the efficacy and safety of testosterone replacement therapy have been raised. In particular, the cardiovascular safety and the beneficial effects of testosterone replacement therapy on general health have been questioned. This review will give an overview of the current evidence for the relationship of LOH and male sexual dysfunction."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-331",
            "name": "Investigating the basis of sexual dysfunction during late-onset hypogonadism"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Investigating the basis of sexual dysfunction during late-onset hypogonadism </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=18100 data-id=16561 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16561.1" data-recommended="" data-doi="10.12688/f1000research.16561.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-331/v1/pdf?article_uuid=84ecdf91-c3c3-480e-b135-9387b19ae226" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-16561-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-16561-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-16561-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Tharakan T, Miah S, Jayasena CN and Minhas S. Investigating the basis of sexual dysfunction during late-onset hypogonadism [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):331 (<a class=new-orange href="https://doi.org/10.12688/f1000research.16561.1" target=_blank>https://doi.org/10.12688/f1000research.16561.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-16561-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=16561 id=track-article-signin-16561 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16561?target=/articles/8-331">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18100 /> <input name=articleId type=hidden value=16561 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Investigating the basis of sexual dysfunction during late-onset hypogonadism</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:tharu.tharakan@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Tharu Tharakan</span></a><a href="https://orcid.org/0000-0003-1010-7576" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1010-7576</div><sup>1,2</sup>,&nbsp;</span><span class="">Saiful Miah<a href="https://orcid.org/0000-0001-5777-518X" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5777-518X</div><sup>1</sup>,&nbsp;</span><span class="">Channa N. Jayasena<sup>2</sup>,&nbsp;</span><span class="">Suks Minhas<sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:tharu.tharakan@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Tharu Tharakan</span></a><a href="http://orcid.org/0000-0003-1010-7576" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1010-7576</div><sup>1,2</sup>,&nbsp;</span><span class="">Saiful Miah<a href="http://orcid.org/0000-0001-5777-518X" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5777-518X</div><sup>1</sup>,&nbsp;</span><span class="">Channa N. Jayasena<sup>2</sup>,&nbsp;</span><span class="">Suks Minhas<sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 25 Mar 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.16561.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK<br/> <sup>2</sup> Section of Investigative Medicine, Department of Medicine, Imperial College London, London, UK<br/> <p> <div class=margin-bottom> Tharu Tharakan <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Saiful Miah <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Channa N. Jayasena <br/> <span>Roles: </span> Supervision, Writing  Review & Editing </div> <div class=margin-bottom> Suks Minhas <br/> <span>Roles: </span> Conceptualization, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=47828-45817></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=47832-45818></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Late-onset hypogonadism (LOH) is the term used to describe the decline in serum testosterone levels associated with increasing age in men above 40 years. A number of symptoms are attributed to LOH, but the most common association is that of sexual dysfunction. LOH has recently come under greater scrutiny with the widespread use of testosterone therapy, and concerns regarding the efficacy and safety of testosterone replacement therapy have been raised. In particular, the cardiovascular safety and the beneficial effects of testosterone replacement therapy on general health have been questioned. This review will give an overview of the current evidence for the relationship of LOH and male sexual dysfunction. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Testosterone replacement therapy, late onset hypogonadism, androgen deprivation, andropause, Prostate cancer </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Tharu Tharakan (<a href="mailto:tharu.tharakan@nhs.net">tharu.tharakan@nhs.net</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Tharu Tharakan </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2019 Tharakan T <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Tharakan T, Miah S, Jayasena CN and Minhas S. Investigating the basis of sexual dysfunction during late-onset hypogonadism [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):331 (<a href="https://doi.org/10.12688/f1000research.16561.1" target=_blank>https://doi.org/10.12688/f1000research.16561.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 25 Mar 2019, <b>8</b>(F1000 Faculty Rev):331 (<a href="https://doi.org/10.12688/f1000research.16561.1" target=_blank>https://doi.org/10.12688/f1000research.16561.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 25 Mar 2019, <b>8</b>(F1000 Faculty Rev):331 (<a href="https://doi.org/10.12688/f1000research.16561.1" target=_blank>https://doi.org/10.12688/f1000research.16561.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e189>Introduction</h2><p class="" id=d15997e192>A number of studies<sup><a href="#ref-1">1</a><a href="#ref-4">4</a></sup> have demonstrated that with increasing age there is an associated decline in serum testosterone levels. Whether this is part of the normal physiological ageing process or a separate pathological entity is controversial. The terminology late-onset hypogonadism (LOH) has been used to describe those patients with an age-related decline in serum testosterone levels, and the most prevalent symptoms are those of sexual dysfunction, particularly decreased morning erections, reduced sexual thoughts, and erectile dysfunction (ED)<sup><a href="#ref-1">1</a>,<a href="#ref-5">5</a></sup>.</p><p class="" id=d15997e209>Interest in LOH has been reported since the mid-20th century. Heller and Myers described the male climateric but noted that it was infrequent and a pathologic accompaniment of the ageing process<sup><a href="#ref-6">6</a></sup>. Additional terms such as andropause, viropause, partial androgen deficiency of the ageing man, and testosterone deficiency syndrome have all been used to describe this age-dependent testosterone decline. There has been a renewed interest in hypogonadism given improvements in testosterone replacement preparations, the rise in life expectancy, and a recent vogue for male rejuvenation treatments. Moreover, there is evidence<sup><a href="#ref-7">7</a>,<a href="#ref-8">8</a></sup> that testosterone deficiency is associated with metabolic syndrome and potentially a long-term increase in cardiovascular mortality. Therefore, it has been suggested that treatment can encourage weight loss and offset the deleterious long-term cardiovascular risks of metabolic syndrome. However, LOH has recently been placed under scrutiny given the widespread use of testosterone replacement therapy (TRT); in 2011, the global sales of testosterone reached an estimated $1.8 billion<sup><a href="#ref-9">9</a></sup>. In addition to this, safety concerns related to the possible increased cardiovascular risk associated with the use of TRT have been raised. Indeed, owing to the media and scientific scrutiny of TRT, there has been a surge of petitioning to the US Food and Drug Administration (FDA) to enforce warnings on medication packaging<sup><a href="#ref-10">10</a></sup>. This review aims to give an overview regarding the epidemiology, pathophysiology, diagnosis and management of LOH and also address the controversies associated with this disorder.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e234>Defining the problem, pathophysiology and epidemiology</h2><p class="" id=d15997e237>Several studies have demonstrated an age-related decline in testosterone and these are summarised in <a href="#T1">Table 1</a><sup><a href="#ref-1">1</a><a href="#ref-4">4</a>,<a href="#ref-11">11</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Studies demonstrating age-related testosterone decline.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d15997e263 class=n-a></a><thead><a name=d15997e265 class=n-a></a><tr><a name=d15997e267 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d15997e269 class=n-a></a>Reference</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15997e272 class=n-a></a>Study type</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15997e275 class=n-a></a>Age range,<br class=br>years</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15997e280 class=n-a></a>Sample<br class=br>size</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15997e285 class=n-a></a>Testosterone sample</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15997e289 class=n-a></a>Results</th></tr></thead><tbody><a name=d15997e294 class=n-a></a><tr><a name=d15997e296 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e298 class=n-a></a>European Male Ageing<br class=br>Study (EMAS)<br class=br>Wu <i>et al</i>.<sup><a href="#ref-1">1</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e311 class=n-a></a>Cross-sectional,<br class=br>prospective,<br class=br>multicentre</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e318 class=n-a></a>4079</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e321 class=n-a></a>3220</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e324 class=n-a></a>Single fasting<br class=br>testosterone (before<br class=br>10 a.m.)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e332 class=n-a></a>Total testosterone decline = 0.04<br class=br>nmol/L year (<i>P</i> &lt;0.001)</td></tr><tr><a name=d15997e341 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e343 class=n-a></a>The Massachusetts Male<br class=br>Aging Study (MMAS)<br class=br>Feldman <i>et al</i>.<sup><a href="#ref-2">2</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e356 class=n-a></a>Cross-sectional<br class=br>and longitudinal<br class=br>estimates</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e363 class=n-a></a>4069</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e366 class=n-a></a>1156</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e369 class=n-a></a>Non-fasting blood<br class=br>samples 4 hours after<br class=br>subject awakening</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e377 class=n-a></a>Cross-sectional results: total<br class=br>testosterone decline = 0.8% per year<br class=br>Longitudinal results: total<br class=br>testosterone decline = 1.6%/year</td></tr><tr><a name=d15997e387 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e389 class=n-a></a>Baltimore Longitudinal<br class=br>Study (BMAS)<br class=br>Harman <i>et al</i>.<sup><a href="#ref-4">4</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e402 class=n-a></a>Longitudinal study</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e405 class=n-a></a>2291</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e408 class=n-a></a>890</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e411 class=n-a></a>Blood samples were in<br class=br>the morning between 7<br class=br>and 9:30 a.m., after an<br class=br>overnight fast</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e421 class=n-a></a>Total testosterone declined from third<br class=br>to ninth decades. The magnitude of<br class=br>the decrease in total testosterone<br class=br>averaged 0.110 nmol/L (3.2 ng/dL)<br class=br>per year.</td></tr><tr><a name=d15997e433 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e435 class=n-a></a>New Mexico Aging Study<br class=br>Morley <i>et al</i>.<sup><a href="#ref-3">3</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e446 class=n-a></a>Longitudinal study</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e449 class=n-a></a>6187</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e452 class=n-a></a>77</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e455 class=n-a></a>Blood samples drawn<br class=br>between 8 and 11 a.m.</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e461 class=n-a></a>Average rate of testosterone decline<br class=br>was 110 ng/dL every 10 years.</td></tr><tr><a name=d15997e467 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e469 class=n-a></a>Rancho Bernardo Study<br class=br>Barrett-Connor <i>et al</i>.<sup><a href="#ref-11">11</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e480 class=n-a></a>Cross-sectional<br class=br>study</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e485 class=n-a></a>5089</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e488 class=n-a></a>856</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e491 class=n-a></a>Blood samples drawn<br class=br>between 7:30 and<br class=br>11 a.m.</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e499 class=n-a></a>Bioavailable testosterone and<br class=br>estradiol decreased significantly with<br class=br>age (<i>P</i> &lt;0.01).</td></tr></tbody></table></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e516>Classification of hypogonadism</h2><p class="" id=d15997e519>Hypogonadism has traditionally been classified into primary or secondary depending upon the aetiology. Primary hypogonadism is due to an intrinsic testicular abnormality resulting in reduced testosterone and elevated luteinising hormone, whereas secondary hypogonadism involves pathology of the pituitary or hypothalamus gland, leading to a disturbance in the hypothalamicpituitarygonadal axis and subsequent reduced testosterone and reduced or normal luteinising hormone. Tajar <i>et al</i>.<sup><a href="#ref-12">12</a></sup> noted that 9.5% of male patients in the European Male Aging Study (EMAS) had normal testosterone but raised luteinising hormone and this compensated hypogonadism was significantly associated with reduced physical activity but not sexual symptoms. The authors felt that compensated hypogonadism should be considered its own clinical entity and that it was a forerunner to overt hypogonadism.</p><p class="" id=d15997e529>The studies in <a href="#T1">Table 1</a> have also documented that associated morbidities play a crucial role in the age-dependent decline of testosterone. Hence, the concept of functional in comparison with organic hypogonadism is emerging<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>. The former is the result of hypothalamus pituitary testis (HPT) axis perturbation due to the presence of associated morbidities. Hence, if the morbidities are adequately treated and removed, functional hypogonadism is potentially reversible<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>. The latter, also known as classical hypogonadism, is the consequence of organic perturbation of the hypothalamicpituitarygonadal axis due to genetic problems, surgery, infective or infiltrative disorders<sup><a href="#ref-14">14</a></sup>. However, despite this hypothesis, evidence suggests that ageing per se can induce organic modifications of the hypothalamicpituitarygonadal axis.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e556>Organic</h2><p class="" id=d15997e559>A number of studies<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup> have shown that with increasing age there is a decline in Leydig cell mass as well as decreased sensitivity to luteinising hormone secretion from the pituitary gland, which leads to a diminished testicular testosterone secretory capacity. Moreover, there is altered neuroendocrine regulation of Leydig cells, leading to a lower threshold for suppression of testosterone production. There is also an independent increase in sexual hormone binding globulin (SHBG) binding capacity, leading to a decrease in bioavailable or free testosterone. These factors are collectively proposed to cause an age-dependent decline in testosterone levels. Furthermore, hypothalamic gonadotrophin-releasing hormone (GnRH) secretion may be reduced in older men when compared with other men<sup><a href="#ref-17">17</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e576>Functional</h2><p class="" id=d15997e579>The Massachusetts Male Aging Study (MMAS) data showed for the first time that healthy men had significantly higher median hormone concentrations at most time points than apparently unhealthy men<sup><a href="#ref-18">18</a></sup>. Similarly, data from the EMAS demonstrated that chronic disease, high body mass index and large waist circumference significantly reduced total, free and bioavailable testosterone concentrations<sup><a href="#ref-19">19</a></sup>. Moreover, the Hypogonadism in Males (HIM) study demonstrated an association between hypogonadism and the conditions of hypertension, hyperlipidaemia, diabetes and obesity (<i>P</i> &lt;0.001)<sup><a href="#ref-20">20</a></sup>.</p><p class="" id=d15997e597>Grossman and Matsumoto<sup><a href="#ref-14">14</a></sup> argue that the management of functional hypogonadism should not be with hormonal replacement therapy but rather through management of the primary disorder such as obesity, diabetes and metabolic syndrome. Accordingly, weight loss, through either a low-calorie diet or bariatric surgery, may improve testosterone levels<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d15997e608>However, some studies suggest that the use of supplemental testosterone therapy inhibits adipocyte lipoprotein lipase activity, thereby reducing free fatty acids taken for storage and improving overall body composition<sup><a href="#ref-22">22</a></sup>. This weight loss also further improves testosterone levels.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e619>Association with the metabolic syndrome</h2><p class="" id=d15997e622>Metabolic syndrome is a cluster of several different risk factors that promote atherosclerotic disease. The diagnosis of metabolic syndrome requires the presence of at least three of the following five criteria: increased waist circumference, raised triglycerides, reduced high-density lipoprotein C, raised blood pressure and raised fasting glucose<sup><a href="#ref-23">23</a></sup>.</p><p class="" id=d15997e629>A large body of evidence suggests a bidirectional relationship between LOH and metabolic derangements<sup><a href="#ref-8">8</a></sup>.</p><p class="" id=d15997e636>Braga-Basaria <i>et al</i>.<sup><a href="#ref-24">24</a></sup> noted that patients undergoing androgen deprivation therapy (ADT) who developed subsequent hypogonadism had a higher prevalence of metabolic syndrome compared with the non-ADT group (<i>P</i> &lt;0.1) and control group (<i>P</i> &lt;0.03). Several pathophysiological mechanisms underpin this relationship, including the observation that testosterone has been demonstrated to stimulate lipolysis and reduce fatty acid storage<sup><a href="#ref-25">25</a><a href="#ref-27">27</a></sup>.</p><p class="" id=d15997e659>Moreover, studies<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup> have shown that TRT can improve insulin sensitivity in hypogonadal men. Accordingly, a number of systematic reviews and meta-analyses have shown that men with higher testosterone levels (range of 449.6605.2 ng/dL) had a 42% lower risk of developing type 2 diabetes<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d15997e674>In line with these data, Yassin <i>et al</i>. reported that treatment with testosterone undecanoate long term in an elderly cohort of men with LOH and ED was able to improve several metabolic parameters, including waist circumference and body mass index, cholesterol levels (low-density lipoprotein and total cholesterol), fasting blood glucose and HBA1c levels, and blood pressure over 5 years<sup><a href="#ref-31">31</a></sup>. However, it should be recognised that long-term and large placebo-controlled trials evaluating the effects of TRT in patients with metabolic syndrome are still lacking<sup><a href="#ref-32">32</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e691>Epidemiology</h2><p class="" id=d15997e694>The lack of a universally accepted definition for LOH makes estimation of its prevalence a major challenge. The HIM study defined LOH purely on biochemical terms and as a morning total serum testosterone of less than 10.4 nmol/L (300 ng/dL). Mulligan <i>et al</i>.<sup><a href="#ref-20">20</a></sup> identified that 38.7% of men over 45 years satisfied the aforementioned criteria. In the Baltimore Longitudinal Study on Ageing, it was found that 19% of men over 60 years had low total testosterone or free testosterone index (total testosterone of less than 11.3 nmol/L (325 ng/dL) or the free testosterone index of less than 0.153 nmol/nmol)<sup><a href="#ref-4">4</a></sup>. The EMAS reviewed nearly 3000 men aged 40 to 79 years old. It concluded that only three sexual symptoms (low libido, ED and spontaneous erections) were related to low testosterone levels. Consequently, a strict definition for LOH as a total serum testosterone of less than 11.1 nmol/L (320 ng/dL) combined with the presence of three sexual symptoms (low libido, ED and spontaneous erections) is proposed. With this definition, it is estimated that only 2.1% of men aged 40 to 79 years had LOH<sup><a href="#ref-1">1</a></sup>. The MMAS also combined clinical symptoms (loss of libido, ED, and mood or sleep disturbances) and biochemical markers (total testosterone of less than 200 ng/dL or free testosterone of less than 8.91 ng/dL) and identified that between 6 and 12.3% of men had symptomatic androgen deficiency<sup><a href="#ref-33">33</a></sup>. In that study, Araujo <i>et al</i>.<sup><a href="#ref-33">33</a></sup> estimated that the crude incidence of androgen deficiency was 12.3 per 1000 person-years. Similarly, the Boston Area Community Health survey combined symptoms with biochemical markers (total testosterone of less than 300 ng/dL and free testosterone of less than 5 ng/dL) and estimated that the prevalence of LOH was 5.6% of men in their cohort of 1475 men<sup><a href="#ref-34">34</a></sup>.</p><p class="" id=d15997e728>The International Society of Andrology (ISA), the International Society for the Study of the Aging Male (ISSAM) and the European Association of Urology (EAU) attempted to standardise terminology in 2008 and defined LOH as a clinical and biochemical syndrome associated with advancing age and characterised by typical symptoms and deficiency in serum testosterone levels<sup><a href="#ref-35">35</a></sup>. Within these guidelines, there was no accepted lower limit for normal, but the consensus was that total testosterone levels above 12 nmol/L (350 ng/dL) do not require testosterone replacement but that men with total serum testosterone levels of less than 8 nmol/L (230 ng/dL) will usually benefit from treatment. These typical symptoms are not clearly defined but include ED, mood or cognitive disturbance, muscle weakness, osteoporosis, and body hair and skin changes.</p><p class="" id=d15997e735>The scientific rationale for the aforementioned definition was based on available scientific data on androgen supplementation therapy and, by their own omission, should be regarded as provisional until higher-level evidence becomes available. Interestingly, they do note that a correlation between low serum testosterone levels in elderly men and ED has still to be conclusively demonstrated<sup><a href="#ref-35">35</a></sup>. For the purpose of this review, we will be focusing only on the impact of LOH on sexual dysfunction.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e745>Clinical presentation</h2><p class="" id=d15997e748>Sexual dysfunction is a broad term which encompasses several symptoms, including ED, premature or delayed ejaculation, and low libido. Male sexual function is dependent on several factors, including hormone levels, general fitness, sexual desire, psychological elements as well as the current state of the couples relationship<sup><a href="#ref-36">36</a></sup>.</p><p class="" id=d15997e755>Many other studies have shown that sexual frequency decreases with age. Given the complex nature of sexual dysfunction, it is difficult to isolate whether this is a physiological, psychological or pathological consequence of ageing. Moreover, if we were to assume it was pathological, several comorbidities (including drugs) could be attributable. A number of studies have demonstrated the association between LOH and male sexual dysfunction (<a href="#T2">Table 2</a>)<sup><a href="#ref-37">37</a><a href="#ref-42">42</a></sup>.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Summary of the evidence demonstrating the association between late-onset hypogonadism and sexual dysfunction.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d15997e779 class=n-a></a><thead><a name=d15997e781 class=n-a></a><tr><a name=d15997e783 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d15997e785 class=n-a></a>Reference</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15997e788 class=n-a></a>Study type</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15997e791 class=n-a></a>Results</th></tr></thead><tbody><a name=d15997e796 class=n-a></a><tr><a name=d15997e798 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e800 class=n-a></a>Boloa <i>et al</i>.<sup><a href="#ref-37">37</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e809 class=n-a></a>Systematic review and<br class=br>meta-analysis of 17 RCTs</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e814 class=n-a></a>In hypogonadal men<br class=br>Testosterone treatment caused a large effect on libido (pooled effect size 1.31, 95%<br class=br>confidence interval 0.402.25).</td></tr><tr><a name=d15997e822 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e824 class=n-a></a>Isidori <i>et al</i>.<sup><a href="#ref-38">38</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e833 class=n-a></a>Meta-analysis of 17<br class=br>randomised placebo-<br class=br>controlled trials</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e840 class=n-a></a>Meta-analysis showed that in men with an average baseline testosterone level below<br class=br>12 nmol/L, testosterone treatment moderately improved the number of nocturnal<br class=br>erections, sexual thoughts and motivation, number of successful intercourses,<br class=br>scores of erectile function, and overall sexual satisfaction.<br class=br>However, meta-regression analysis showed that the effects of testosterone<br class=br>supplementation on erectile function, but not libido, were inversely related to the<br class=br>mean baseline testosterone concentration.</td></tr><tr><a name=d15997e857 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e859 class=n-a></a>Jain <i>et al</i>.<sup><a href="#ref-43">43</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e868 class=n-a></a>Meta-analysis of 16<br class=br>studies (five RCTs)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e873 class=n-a></a>In five RCTs, erectile function response to TRT was 65.4% versus 16.7% (<i>P</i> &lt;0.001).</td></tr><tr><a name=d15997e880 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e882 class=n-a></a>Tsertsvadze <i>et al</i>.<sup><a href="#ref-42">42</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e891 class=n-a></a>Meta-analysis of 15 RCTs</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e894 class=n-a></a>Inconsistent data. Results for most trials suggested that TRT was no different from placebo.</td></tr><tr><a name=d15997e898 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e900 class=n-a></a>Corona <i>et al</i>.<sup><a href="#ref-39">39</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e909 class=n-a></a>Meta-analysis of 41 RCTs</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e912 class=n-a></a>Forty-one studies were included and supplementary testosterone improved both<br class=br>spontaneous and sex-related erections as well as libido in hypogonadal patients.</td></tr><tr><a name=d15997e919 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e921 class=n-a></a>Corona <i>et al</i>.<sup><a href="#ref-40">40</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e930 class=n-a></a>Meta-analysis of 14 RCTs</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15997e933 class=n-a></a>TRT induced a significant improvement of the erectile function score component<br class=br>compared with placebo (<i>P</i> &lt;0.0001).</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d15997e946 class=n-a></a><p id=FN2> RCT, randomised controlled trial; TRT, testosterone replacement therapy.</p></div></div></div><p class="" id=d15997e954>The above studies have several limitations. Boloa <i>et al</i>.<sup><a href="#ref-37">37</a></sup> demonstrated that TRT improved the libido of hypogonadal men but had no impact on erectile function or overall sexual satisfaction. Isidori <i>et al</i>.<sup><a href="#ref-38">38</a></sup> noted a significant heterogenicity in effect sizes and risk of publication bias.</p><p class="" id=d15997e972>The meta-analysis by Corona <i>et al</i>.<sup><a href="#ref-39">39</a></sup>, who reviewed the effects of testosterone treatment on sexual dysfunction, showed that TRT resulted in an improvement of all sexual function domains, including libido and erectile and orgasmic function. However, the effect was observed only when studies enrolling hypogonadal (total testosterone of less than 12 nM) men were considered. In addition, an inverse relationship between testosterone levels at enrolment and TRT outcomes was documented. Moreover, the same study showed that the effects of TRT were lower in the presence of higher associated morbidities. This may be reflective of a more severe ED. Accordingly, a more recent meta-analysis<sup><a href="#ref-40">40</a></sup> produced by the same group, focusing only on those studies using the International Index of Erectile Function as an outcome measure, provided evidence that TRT alone is able to significantly improve milder forms of ED.</p><p class="" id=d15997e986>These studies are in contrast with a systematic review by Huo <i>et al</i>. in 2016<sup><a href="#ref-41">41</a></sup>. This study included 156 randomised controlled trials (RCTs) and noted that testosterone supplementation did not consistently improve sexual function or satisfaction. Moreover, testosterone supplementation was noted to be ineffective in treating ED. However, this was only a systematic review based on the authors evaluation without any statistical analysis as support. Tsertsvadze <i>et al</i>.<sup><a href="#ref-42">42</a></sup> demonstrated similar findings in a meta-analysis which did not find any significant improvements of TRT on ED, either individually or when supplemented with PDE5 inhibitors. However, only a limited number of RCTs were included in this study.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1006>Investigations</h2><p class="" id=d15997e1009>The diagnosis of LOH relies on a combination of biochemical and clinical features. This is because men with symptoms of sexual dysfunction and LOH often have a normal testosterone and some asymptomatic patients may have reduced testosterone.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1015>Testosterone measurement</h2><div class=section><a name=d15997e1018 class=n-a></a><h3 class=section-title>Parameters</h3><p class="" id=d15997e1023>Serum total testosterone is the favoured biochemical marker to diagnose LOH, and the EAU, ISSAM and ISA recommendations are that a total serum testosterone greater than 12 nmol/L does not require substitution. However, there is no universal agreement on the lower limits of normal testosterone measurements. Sansone <i>et al</i>.<sup><a href="#ref-44">44</a></sup> argue that levels below 8 nmol/L are widely considered to require treatment but that levels between 8 and 12 nmol/L represent a grey area where the effects of testosterone are dependent on the patients sensitivity to androgens. In this grey area, the authors recommend repeating the total testosterone and also calculating the free testosterone by the combination of total testosterone and SHBG<sup><a href="#ref-45">45</a></sup>. When hypogonadism is confirmed, prolactin and gonadotropin levels should be measured to exclude hyperprolactinemia and to better characterise the origin of the problem (i.e is it, primary or secondary?).</p></div><div class=section><a name=d15997e1038 class=n-a></a><h3 class=section-title>Variability in testosterone measurements</h3><p class="" id=d15997e1043>Circulating testosterone levels are subject to circadian variation, so blood testing should be performed in the morning. Furthermore, levels of serum testosterone decrease by 25% following glucose ingestion, so fasting samples are most reliable<sup><a href="#ref-46">46</a></sup>.</p><p class="" id=d15997e1050>Furthermore, studies have demonstrated that testosterone measurements can vary greatly. Swerdloff<sup><a href="#ref-47">47</a></sup> noted that 18% of patients who had a normal average testosterone level over 24 hours had single or multiple hypogonadal readings. Hence, usually at least two measurements are required to confirm the diagnosis of hypogonadism.</p></div><div class=section><a name=d15997e1058 class=n-a></a><h3 class=section-title>Variability in measurement</h3><p class="" id=d15997e1063>A wide variety of immunoassays are used to measure serum testosterone. Wang <i>et al</i>.<sup><a href="#ref-48">48</a></sup> demonstrated variations in the levels of serum total testosterone dependent on the assay used and when compared to the gold standard of mass spectrometry. However, data from the EMAS showed that results derived from reliable immunoassays are well correlated with mass spectrometry data in men<sup><a href="#ref-49">49</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1081>Assessments of symptoms</h2><p class="" id=d15997e1084>The symptom most associated with hypogonadism is low libido. Questionnaires such as the Aging Male Symptom Score (AMS), Androgen Deficiency in Aging Men (ADAM) and the MMAS questionnaire have been shown to have a good sensitivity but lack specificity at diagnosing LOH<sup><a href="#ref-36">36</a>,<a href="#ref-50">50</a>,<a href="#ref-51">51</a></sup>. Hence, the use of these self-reported tools for widespread screening of LOH in ageing men should be avoided. In addition, biochemical measurements of testosterone are essential for the diagnosis of LOH. Corona <i>et al</i>. validated a 12-item structured interview (ANDROTEST) specifically designed for men seeking consultation for sexual dysfunction, although the sensitivity and specificity of this test at detecting low total testosterone (defined as less than 10.4 n/L) were low: 68% and 65% respectively<sup><a href="#ref-52">52</a></sup>.</p><p class="" id=d15997e1104>What complicates the diagnosis of LOH is that sexual dysfunction with ageing is often multifactorial in nature, combining metabolic, cardiovascular and psychological issues. Moreover, there is often a reluctance to seek medical attention for sexual dysfunction, especially in the elderly where there is a belief that sexual dysfunction is a normal process of ageing. Corona <i>et al</i>.<sup><a href="#ref-36">36</a></sup> noted that the prevalence of subjects seeking medical care for ED peaked at middle age and decreased thereafter. Therefore, it is difficult to gauge the scale of the issue and also the minority of patients who present for consultation may reflect an extremity.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1118>Management</h2><div class=section><a name=d15997e1121 class=n-a></a><h3 class=section-title>Conservative management</h3><p class="" id=d15997e1126>As reported above, obesity is frequently associated with LOH. Camacho <i>et al</i>.<sup><a href="#ref-53">53</a></sup> noted that weight loss can reverse the age-related decline in testosterone and free testosterone. Moreover, they demonstrated that, when adjusting forpotential cofounders, a weight decrease of at least 10% led to an increase in testosterone (2.9 nmol/L) and SHBG (13.6 nmol/L) (<i>P</i> &lt;0.01 for both).</p><p class="" id=d15997e1139>Corona <i>et al</i>.<sup><a href="#ref-21">21</a></sup> performed a meta-analysis of 24 studies reviewing the impact of weight loss on testosterone levels. In this study, weight loss was associated with a relevant increase in gonadotropins and in bound and unbound testosterone, with a decline in the oestrogen level. The testosterone rise was greater with more weight loss. The above evidence highlights the importance of first trialling lifestyle changes in order to facilitate weight loss and thus avoid the potential side effects related to TRT.</p><p class="" id=d15997e1149>There is an ongoing debate with regard to the impact of improvements in sleep quality and duration on serum testosterone. Wittert<sup><a href="#ref-54">54</a></sup> noted that although some studies<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup> have shown that treatment of obstructive sleep apnoea (OSA) can improve serum testosterone levels, many others have shown equivocal results. Moreover, when age and obesity are adjusted for, OSA appears to have no direct effect on serum testosterone. Rather than duration of sleep, the timing of sleep seems to be more important on testosterone levels. Schmid <i>et al</i>.<sup><a href="#ref-57">57</a></sup> noted that 4.5 hours of sleep restricted to the first half of the night markedly decreased morning testosterone (<i>P</i> 0.05).</p><p class="" id=d15997e1173>Studies have identified that the use of PDE5 inhibitors can improve erectile function in hypogonadal patients<sup><a href="#ref-58">58</a></sup> and can increase serum testosterone levels<sup><a href="#ref-59">59</a></sup>.</p><p class="" id=d15997e1185>Therefore, Grossmann and Matsumoto<sup><a href="#ref-14">14</a></sup> argue that first-line management should incorporate lifestyle measures as they have the potential to improve testosterone levels and negate the need for TRT. Moreover, this should be accompanied by evidence-based management of the clinical problem which would include treating any ED with a PDE5 inhibitor.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1196>Infertility</h2><p class="" id=d15997e1199>The use of exogenous testosterone causes a negative feedback mechanism in the hypothalamicpituitarygonadal pathway resulting in reduced intratesticular testosterone and subsequent impaired spermatogenesis. This mechanism has been demonstrated to be both dose- and duration-dependent<sup><a href="#ref-60">60</a></sup>. Our current understanding of the impact of exogenous testosterone on spermatogenesis is from data on trials using testosterone as a male contraceptive. A dose of 200 mg testosterone enanthate weekly by intramuscular injection induced azoospermia at a mean time of 120 days<sup><a href="#ref-61">61</a></sup>. Liu <i>et al</i>. compared 30 studies evaluating the time of sperm recovery and noted that the typical probabilities of recovery to 20 million per millilitre were 67% (6172) within 6 months, 90% (8593) within 12 months, and 100% within 24 months<sup><a href="#ref-62">62</a></sup>.</p><p class="" id=d15997e1217>However, other studies have suggested that the adverse effects of exogenous testosterone may be longer-lasting with a proportion of patients not returning to baseline<sup><a href="#ref-63">63</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1227>Human chorionic gonadotropin</h2><p class="" id=d15997e1230>Human chorionic gonadotropin (HCG) stimulates Leydig cells to produce testosterone without impairing spermatogenesis. Studies have demonstrated that HCG can improve testosterone and induce spermatogenesis in hypogonadotrophic hypogonadism patients<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup>. Moreover, when low-dose HCG is used in conjunction with exogenous testosterone, it provides a protective effect for intratesticular spermatogenesis and sperm counts are maintained<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1250>Selective oestrogen receptor modulators</h2><p class="" id=d15997e1253>Selective oestrogen receptor modulators (SERMs) have been shown to stimulate oestrogen receptors and thereby increase the production of gonadotropins and subsequently testosterone. A meta-analysis demonstrated that SERMs were associated with a statistically significant increased pregnancy rate compared with controls (pooled odds ratio [OR] 2.42, 95% confidence interval [CI] 1.473.94; <i>P</i> = 0.0004) and a significant increase in sperm concentration (weighted mean difference 5.24, 95% CI 2.1288.37; <i>P</i> = 0.001)<sup><a href="#ref-68">68</a></sup>.</p><p class="" id=d15997e1266>Clomiphene citrate has been demonstrated to increase testosterone but also improve hypogonadal symptoms<sup><a href="#ref-69">69</a>,<a href="#ref-70">70</a></sup>. However, one study indicated that the use of clomiphene citrate is less effective than TRT at increasing serum testosterone levels and improving hypogonadal symptoms and libido<sup><a href="#ref-71">71</a></sup>. Enclomiphene citrate is a shorter-acting preparation of clomiphene citrate that has been shown to improve sperm counts but also testosterone levels equivalent to exogenous testosterone<sup><a href="#ref-72">72</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1287>Aromatase inhibitors</h2><p class="" id=d15997e1290>Aromatase inhibitors prevent the conversion of estradiol and therefore prevent the negative feedback effect of estradiol on the hypothalamicpituitarygonadal axis, thereby increasing testosterone levels<sup><a href="#ref-73">73</a></sup>. Leder <i>et al</i>.<sup><a href="#ref-74">74</a></sup> demonstrated that the use of anastrozole significantly increased serum testosterone levels but had no significant effect on erectile function compared with control groups. Aromatase inhibitors can commonly cause hot flashes, night sweats, weight gain, insomnia, myalgia and arthralgia. Moreover, patients are at increased risk of osteopenia<sup><a href="#ref-73">73</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1311>Controversies surrounding testosterone replacement therapy</h2><p class="" id=d15997e1314>There can be little doubt that sales of testosterone supplementation have increased dramatically in the last decade. Handelsman<sup><a href="#ref-9">9</a></sup> noted that between the years 2000 and 2011, total testosterone sales have increased 12-fold globally, with an estimated rise to $1.8 billion in 2011. Gan <i>et al</i>.<sup><a href="#ref-75">75</a></sup> note that, between 2001 and 2010, the number of prescriptions for supplementary testosterone therapy increased by nearly 90% with a 267% escalation of costs to the National Health Service. Of note, a study by the FDA noted that more than 80% of prescription testosterone users in the US were men between 40 and 74 years of age<sup><a href="#ref-76">76</a></sup>. This implies that LOH is the disorder contributing to the surge in testosterone sales.</p><p class="" id=d15997e1332>This marked rise in testosterone sales has been aided by the development of more convenient means of administering testosterone. Historically, testosterone supplementation was reliant upon depot injection therapy every few weeks, which caused discomfort and large testosterone level fluctuations, which led to patients complaining of variations in sexual activity and mood. Moreover, these fluctuations could lead to potentially dangerous side effects such as polycythaemia due to the effect of testosterone to stimulate erythropoeisis<sup><a href="#ref-77">77</a></sup>. Transdermal testosterone preparations were introduced at the turn of the century and are now the most frequently used. Transdermal testosterone preparations normalise serum testosterone levels with minimal side effects but require active patient compliance. Some patients therefore benefit from taking three monthly depot preparations of testosterone.</p><p class="" id=d15997e1339>Another factor leading to the rise in testosterone sales has been the significant advertising campaigns. Busnelli <i>et al</i>.<sup><a href="#ref-78">78</a></sup> note that both direct and indirect marketing campaigns have advertised testosterone replacement as an elixir of eternal youth and social accomplishment and this had promoted disease mongering.</p><p class="" id=d15997e1349>Bandari <i>et al</i>.<sup><a href="#ref-79">79</a></sup> performed a systematic review of studies evaluating marketing and testosterone treatment in the US. The authors noted that 10 to 26.6% of men prescribed TRT did not undergo serum testosterone evaluation; of those who did, a significant proportion of men did not meet laboratory criteria for hypogonadism. This illustrates that many patients are being treated with TRT without appropriate investigations, which leads to the potential for drug abuse.</p><p class="" id=d15997e1360>Given that the rise in TRT sales was not evidence-based and given associated safety concerns, the FDA highlighted that prescription of testosterone products are approved only for men with classical hypogonadism, due to disorders of the testicles, pituitary gland or hypothalamus. The same recommendations also emphasise that the benefit and safety of testosterone medications have not been established for the treatment of low testosterone levels due to ageing, even if a mans symptoms seem related to low testosterone<sup><a href="#ref-80">80</a></sup>.</p><p class="" id=d15997e1367>However, it is important to recognise that in animal models of metabolic syndrome obtained by feeding rabbits for 12 weeks with a high-fat diet, metabolic derangements can induce a hypothalamic inflammation leading to an impairment of GnRH secretion. Hence, obesity and its related sequelae can cause organic damage at central levels<sup><a href="#ref-81">81</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1378>Testosterone therapy</h2><p class="" id=d15997e1381>Following a trial of conservative management, testosterone replacement can be commenced. The evidence supporting the use of both a PDE5 inhibitor and testosterone replacement to improve ED is equivocal<sup><a href="#ref-82">82</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1391>Safety of testosterone replacement therapy</h2><div class=section><a name=d15997e1394 class=n-a></a><h3 class=section-title>Prostate cancer</h3><p class="" id=d15997e1399>Huggins and Hodges<sup><a href="#ref-83">83</a></sup> were awarded a Nobel Prize in 1967 for demonstrating that testosterone suppression induced prostate cancer regression. However, historical fears that TRT increased the risk of prostate cancer have been quelled by several studies<sup><a href="#ref-84">84</a>,<a href="#ref-85">85</a></sup>. Morgentaler and Traish<sup><a href="#ref-86">86</a></sup> introduced the saturation model theory to explain the apparent paradox that ADT can treat prostate cancer but testosterone therapy does not increase susceptibility. This model postulates that whilst testosterone acts as a critical factor to prostatic tissue growth, there is a saturation point for androgen receptors at which further increases in testosterone will have no detrimental effects. Moreover, there is evidence that TRT is safe in patients who have undergone treatment for prostate cancer<sup><a href="#ref-87">87</a>,<a href="#ref-88">88</a></sup> and those undergoing active surveillance<sup><a href="#ref-89">89</a></sup>.</p></div><div class=section><a name=d15997e1429 class=n-a></a><h3 class=section-title>Cardiovascular events</h3><p class="" id=d15997e1434>The issue of testosterone therapy and cardiovascular risk is one of controversy and has been investigated by several systematic reviews<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a>,<a href="#ref-90">90</a>,<a href="#ref-91">91</a></sup>. Whereas the FDA offers caution about the potential cardiovascular risks of testosterone therapy, the European Medicines Agency supports the cardiovascular safety of testosterone supplementation, if prescribed and followed in accordance with the current guidelines. Further longitudinal studies are needed to define whether testosterone treatment affects cardiovascular risk in men with LOH.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1454>Erythrocytosis</h2><p class="" id=d15997e1457>Testosterone replacement can cause erythrocytosis<sup><a href="#ref-92">92</a>,<a href="#ref-93">93</a></sup>. A meta-analysis incorporating 51 studies demonstrated that exogenous testosterone caused a significant increase in haemoglobin and haematocrit<sup><a href="#ref-90">90</a></sup>. However, the pathological mechanism that underpins this haemoconcentration and its potential implications in men is poorly understood<sup><a href="#ref-94">94</a></sup>. Moreover, Rhoden and Morgentaler<sup><a href="#ref-95">95</a></sup> note that there have been no reported testosterone-associated thromboembolic events. The evidence linking raised haematocrit and the development of venous thromboembolism is conflicting, and RCTs are needed to evaluate the risk further<sup><a href="#ref-96">96</a>,<a href="#ref-97">97</a></sup>.</p><div class=section><a name=d15997e1486 class=n-a></a><h3 class=section-title>Infertility</h3><p class="" id=d15997e1491>Testosterone therapy can impair spermatogenesis. This has been discussed earlier; however, if all conservative and alternative therapies have been exhausted, then consideration should be given to nasal testosterone therapy. Masterson <i>et al</i>.<sup><a href="#ref-98">98</a></sup> have demonstrated that Natesto increases serum testosterone but maintains gonadotrophin and semen parameters. This is only one study and further research is needed.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1505>Monitoring</h2><p class="" id=d15997e1508>Prior to the start of TRT, prostate-specific antigen (PSA), haematocrit, digital rectal examination and cardiovascular risk assessment should be performed. EAU guidelines<sup><a href="#ref-99">99</a></sup> recommend that treatment be assessed at 3, 6 and 12 months and annually thereafter. Furthermore, the EAU states that there is insufficient evidence to define an optimum serum testosterone level. At these intervals, repeat PSA and haematocrit should be measured; if haematocrit levels increase above 0.54, then dose adjustment or discontinuation is suggested along with phlebotomy. The guidelines do not specify a precise PSA level that mandates investigation but rather that subjects with a substantial or continuous increase in PSA level need to be investigated to exclude prostate cancer<sup><a href="#ref-99">99</a></sup>. The International Society for Sexual Medicine<sup><a href="#ref-100">100</a></sup> has similar recommendations and monitoring periods but stipulates that a PSA increase of 1.4 ng/nL within 1 year or a PSA velocity of more than 0.4 ng/mL necessitates further investigation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15997e1526>Conclusions: Does late-onset hypogonadism result in sexual dysfunction?</h2><p class="" id=d15997e1529>LOH remains a diverse clinical entity in terms of diagnosis, investigation and management. There can be no doubt that global testosterone sales have risen substantially in the last century, and it is unclear what proportion of patients have actually benefited from treatment. Moreover, the exact rationale for the use of testosterone in these patients is ambiguous as an FDA study noted that 28% of men who received a new testosterone prescription had no evidence of a prior serum testosterone measurement<sup><a href="#ref-76">76</a></sup>. Furthermore, objective evaluation of symptoms with patient-reported outcome measures has inherent difficulties in interpretation with non-validated end points. Sexual dysfunction remains a complex multifactorial condition, and whilst there is evidence to imply an association between LOH and sexual dysfunction, there are no overwhelming data to demonstrate causality between testosterone levels and LOH symptoms in the elderly population. LOH should not be treated purely on biochemical terms. Zitzmann <i>et al</i>.<sup><a href="#ref-101">101</a></sup> noted that although the prevalence of loss of libido increases with a total testosterone concentration of less than 15 nmol/L, only 41% of patients with total testosterone below this threshold had loss of libido. Equally, the data that TRT improves sexual function are equivocal. Corona <i>et al</i>.<sup><a href="#ref-102">102</a></sup> noted that LOH can be attributed to different sexual symptoms depending on the age group. This highlights the importance of an individualised care plan for each patient presenting with LOH and sexual dysfunction. Given the association of LOH with metabolic syndrome and obesity, all patients should first undergo conservative management via weight loss and optimisation of co-morbidities. Should this fail, it would be appropriate to trial TRT with the caveat that the literature supporting the efficacy of TRT in this clinical setting is inconclusive.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d15997e1 class=n-a></a><h2 class=main-title id=d16350>Grant information</h2><p>The authors declare that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d15997e1554 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d16675>References</h2><div class="section ref-list"><a name=d15997e1554 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/3674958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e1561 class=n-a></a>Wu FC, Tajar A, Beynon JM, <i> et al.</i>: Identification of late-onset hypogonadism in middle-aged and elderly men. <i>N Engl J Med.</i> 2010; <b>363</b>(2): 123135. <a target=xrefwindow id=d15997e1572 href="http://www.ncbi.nlm.nih.gov/pubmed/20554979">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1575 href="https://doi.org/10.1056/NEJMoa0911101">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/3674958">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d15997e1588 class=n-a></a>Feldman HA, Longcope C, Derby CA, <i> et al.</i>: Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. <i>J Clin Endocrinol Metab.</i> 2002; <b>87</b>(2): 589598. <a target=xrefwindow id=d15997e1599 href="http://www.ncbi.nlm.nih.gov/pubmed/11836290">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1602 href="https://doi.org/10.1210/jcem.87.2.8201">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d15997e1611 class=n-a></a>Morley JE, Kaiser FE, Perry HM 3rd, <i> et al.</i>: Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. <i>Metabolism.</i> 1997; <b>46</b>(4): 4103. <a target=xrefwindow id=d15997e1622 href="http://www.ncbi.nlm.nih.gov/pubmed/9109845">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1625 href="https://doi.org/10.1016/S0026-0495(97)90057-3">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d15997e1634 class=n-a></a>Harman SM, Metter EJ, Tobin JD, <i> et al.</i>: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. <i>J Clin Endocrinol Metab.</i> 2001; <b>86</b>(2): 724731. <a target=xrefwindow id=d15997e1645 href="http://www.ncbi.nlm.nih.gov/pubmed/11158037">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1648 href="https://doi.org/10.1210/jcem.86.2.7219">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d15997e1657 class=n-a></a>Corona G, Maseroli E, Rastrelli G, <i> et al.</i>: Characteristics of compensated hypogonadism in patients with sexual dysfunction. <i>J Sex Med.</i> 2014; <b>11</b>(7): 18231834. <a target=xrefwindow id=d15997e1668 href="http://www.ncbi.nlm.nih.gov/pubmed/24774537">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1671 href="https://doi.org/10.1111/jsm.12549">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d15997e1681 class=n-a></a>Heller CG, Myers GB: The male climacteric, its symptomatology, diagnosis and treatment use of urinary gonadotropins, therapeutic test with testosterone propionate and testicular biopsies in delineating the male climacteric from psychoneurosis and psychogenic impotence. <i>JAMA.</i> 1944; <b>126</b>(8): 472477. <a target=xrefwindow id=d15997e1689 href="https://doi.org/10.1001/jama.1944.02850430006003">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d15997e1698 class=n-a></a>Salam R, Kshetrimayum AS, Keisam R: Testosterone and metabolic syndrome: The link. <i>Indian J Endocrinol Metab.</i> 2012; <b>16 Suppl 1</b>: S129. <a target=xrefwindow id=d15997e1706 href="http://www.ncbi.nlm.nih.gov/pubmed/22701831">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1709 href="https://doi.org/10.4103/2230-8210.94248">Publisher Full Text </a> | <a target=xrefwindow id=d15997e1712 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3354945">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d15997e1721 class=n-a></a>Corona G, Rastrelli G, Monami M, <i> et al.</i>: Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. <i>Eur J Endocrinol.</i> 2011; <b>165</b>(5): 687701. <a target=xrefwindow id=d15997e1732 href="http://www.ncbi.nlm.nih.gov/pubmed/21852391">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1735 href="https://doi.org/10.1530/EJE-11-0447">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d15997e1744 class=n-a></a>Handelsman DJ: Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse. <i>Med J Aust.</i> 2013; <b>199</b>(8): 54851. <a target=xrefwindow id=d15997e1752 href="http://www.ncbi.nlm.nih.gov/pubmed/24138381">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1755 href="https://doi.org/10.5694/mja13.10111">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d15997e1764 class=n-a></a>Corona GG, Rastrelli G, Maseroli E, <i> et al.</i>: Testosterone Replacement Therapy and Cardiovascular Risk: A Review. <i>World J Mens Health.</i> 2015; <b>33</b>(3): 13042. <a target=xrefwindow id=d15997e1775 href="http://www.ncbi.nlm.nih.gov/pubmed/26770933">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1778 href="https://doi.org/10.5534/wjmh.2015.33.3.130">Publisher Full Text </a> | <a target=xrefwindow id=d15997e1782 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4709429">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d15997e1791 class=n-a></a>Barrett-Connor E, Von Mhlen DG, Kritz-Silverstein D: Bioavailable Testosterone and Depressed Mood in Older Men: The Rancho Bernardo Study. <i>J Clin Endocrinol Metab.</i> 1999; <b>84</b>(2): 573577. <a target=xrefwindow id=d15997e1799 href="http://www.ncbi.nlm.nih.gov/pubmed/10022418">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1802 href="https://doi.org/10.1210/jcem.84.2.5495">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d15997e1812 class=n-a></a>Tajar A, Forti G, O'Neill TW, <i> et al.</i>: Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. <i>J Clin Endocrinol Metab.</i> 2010; <b>95</b>(4): 18101818. <a target=xrefwindow id=d15997e1823 href="http://www.ncbi.nlm.nih.gov/pubmed/20173018">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1826 href="https://doi.org/10.1210/jc.2009-1796">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733875970"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e1835 class=n-a></a>Corona G, Rastrelli G, Di Pasquale G, <i> et al.</i>: Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies. <i>J Sex Med.</i> 2018; <b>15</b>(9): 12601271. <a target=xrefwindow id=d15997e1846 href="http://www.ncbi.nlm.nih.gov/pubmed/30145097">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1849 href="https://doi.org/10.1016/j.jsxm.2018.06.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733875970">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727683066"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e1862 class=n-a></a>Grossmann M, Matsumoto AM: A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. <i>J Clin Endocrinol Metab.</i> 2017; <b>102</b>(3): 10671075. <a target=xrefwindow id=d15997e1870 href="http://www.ncbi.nlm.nih.gov/pubmed/28359097">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1873 href="https://doi.org/10.1210/jc.2016-3580">Publisher Full Text </a> | <a target=xrefwindow id=d15997e1876 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5477803">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727683066">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d15997e1889 class=n-a></a>Kaufman JM, Vermeulen A: The decline of androgen levels in elderly men and its clinical and therapeutic implications. <i>Endocr Rev.</i> 2005; <b>26</b>(6): 833876. <a target=xrefwindow id=d15997e1897 href="http://www.ncbi.nlm.nih.gov/pubmed/15901667">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1900 href="https://doi.org/10.1210/er.2004-0013">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d15997e1909 class=n-a></a>Buvat J, Maggi M, Guay A, <i> et al.</i>: Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. <i>J Sex Med.</i> 2013; <b>10</b>(1): 245284. <a target=xrefwindow id=d15997e1920 href="http://www.ncbi.nlm.nih.gov/pubmed/22971200">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1923 href="https://doi.org/10.1111/j.1743-6109.2012.02783.x">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d15997e1932 class=n-a></a>Kaufman JM, Giri M, Deslypere JM, <i> et al.</i>: Influence of age on the responsiveness of the gonadotrophs to luteinizing hormone-releasing hormone in males. <i>J Clin Endocrinol Metab.</i> 1991; <b>72</b>(6): 12551260. <a target=xrefwindow id=d15997e1943 href="http://www.ncbi.nlm.nih.gov/pubmed/2026746">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1946 href="https://doi.org/10.1210/jcem-72-6-1255">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d15997e1956 class=n-a></a>Mohr BA, Guay AT, ODonnell AB, <i> et al.</i>: Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. <i>Clin Endocrinol (Oxf).</i> 2005; <b>62</b>(1): 6473. <a target=xrefwindow id=d15997e1967 href="http://www.ncbi.nlm.nih.gov/pubmed/15638872">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1970 href="https://doi.org/10.1111/j.1365-2265.2004.02174.x">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d15997e1979 class=n-a></a>Wu FC, Tajar A, Pye SR, <i> et al.</i>: Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. <i>J Clin Endocrinol Metab.</i> 2008; <b>93</b>(7): 27372745. <a target=xrefwindow id=d15997e1990 href="http://www.ncbi.nlm.nih.gov/pubmed/18270261">PubMed Abstract </a> | <a target=xrefwindow id=d15997e1993 href="https://doi.org/10.1210/jc.2007-1972">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d15997e2002 class=n-a></a>Mulligan T, Frick MF, Zuraw QC, <i> et al.</i>: Prevalence of hypogonadism in males aged at least 45 years: the HIM study. <i>Int J Clin Pract.</i> 2006; <b>60</b>(7): 7629. <a target=xrefwindow id=d15997e2013 href="http://www.ncbi.nlm.nih.gov/pubmed/16846397">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2016 href="https://doi.org/10.1111/j.1742-1241.2006.00992.x">Publisher Full Text </a> | <a target=xrefwindow id=d15997e2020 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1569444">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d15997e2029 class=n-a></a>Corona G, Rastrelli G, Monami M, <i> et al.</i>: Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. <i>Eur J Endocrinol.</i> 2013; <b>168</b>(6): 829843. <a target=xrefwindow id=d15997e2040 href="http://www.ncbi.nlm.nih.gov/pubmed/23482592">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2043 href="https://doi.org/10.1530/EJE-12-0955">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730651239"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e2052 class=n-a></a>Corona G, Giagulli VA, Maseroli E, <i> et al.</i>: Testosterone supplementation and body composition: results from a meta-analysis of observational studies. <i>J Endocrinol Invest.</i> 2016; <b>39</b>(9): 967981. <a target=xrefwindow id=d15997e2063 href="http://www.ncbi.nlm.nih.gov/pubmed/27241317">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2066 href="https://doi.org/10.1007/s40618-016-0480-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730651239">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d15997e2079 class=n-a></a>Grundy SM, Cleeman JI, Daniels SR, <i> et al.</i>: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. <i>Circulation.</i> 2005; <b>112</b>(17): 27352752. <a target=xrefwindow id=d15997e2090 href="http://www.ncbi.nlm.nih.gov/pubmed/16157765">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2093 href="https://doi.org/10.1161/CIRCULATIONAHA.105.169404">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718357919"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e2103 class=n-a></a>Braga-Basaria M, Dobs AS, Muller DC, <i> et al.</i>: Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. <i>J Clin Oncol.</i> 2006; <b>24</b>(24): 39793983. <a target=xrefwindow id=d15997e2114 href="http://www.ncbi.nlm.nih.gov/pubmed/16921050">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2117 href="https://doi.org/10.1200/JCO.2006.05.9741">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718357919">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d15997e2130 class=n-a></a>De Pergola G: The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. <i>Int J Obes Relat Metab Disord.</i> 2000; <b>24 Suppl 2</b>): S5963. <a target=xrefwindow id=d15997e2138 href="http://www.ncbi.nlm.nih.gov/pubmed/10997611">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2141 href="https://doi.org/10.1038/sj.ijo.0801280">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d15997e2150 class=n-a></a>Page ST, Amory JK, Bowman FD, <i> et al.</i>: Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. <i>J Clin Endocrinol Metab.</i> 2005; <b>90</b>(3): 15021510. <a target=xrefwindow id=d15997e2161 href="http://www.ncbi.nlm.nih.gov/pubmed/15572415">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2164 href="https://doi.org/10.1210/jc.2004-1933">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d15997e2173 class=n-a></a>Kapoor D, Goodwin E, Channer KS, <i> et al.</i>: Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. <i>Eur J Endocrinol.</i> 2006; <b>154</b>(6): 899906. <a target=xrefwindow id=d15997e2184 href="http://www.ncbi.nlm.nih.gov/pubmed/16728551">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2187 href="https://doi.org/10.1530/eje.1.02166">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d15997e2196 class=n-a></a>Pitteloud N, Mootha VK, Dwyer AA, <i> et al.</i>: Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. <i>Diabetes Care.</i> 2005; <b>28</b>(7): 163642. <a target=xrefwindow id=d15997e2207 href="http://www.ncbi.nlm.nih.gov/pubmed/15983313">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2210 href="https://doi.org/10.2337/diacare.28.7.1636">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d15997e2219 class=n-a></a>Jones TH, Arver S, Behre HM, <i> et al.</i>: Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). <i>Diabetes Care.</i> 2011; <b>34</b>(4): 828837. <a target=xrefwindow id=d15997e2230 href="http://www.ncbi.nlm.nih.gov/pubmed/21386088">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2233 href="https://doi.org/10.2337/dc10-1233">Publisher Full Text </a> | <a target=xrefwindow id=d15997e2237 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3064036">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d15997e2247 class=n-a></a>Ding EL, Song Y, Malik VS, <i> et al.</i>: Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. <i>JAMA.</i> 2006; <b>295</b>(11): 128899. <a target=xrefwindow id=d15997e2258 href="http://www.ncbi.nlm.nih.gov/pubmed/16537739">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2261 href="https://doi.org/10.1001/jama.295.11.1288">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d15997e2270 class=n-a></a>Yassin DJ, Doros G, Hammerer PG, <i> et al.</i>: Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. <i>J Sex Med.</i> 2014; <b>11</b>(6): 15671576. <a target=xrefwindow id=d15997e2281 href="http://www.ncbi.nlm.nih.gov/pubmed/24712761">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2284 href="https://doi.org/10.1111/jsm.12523">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d15997e2293 class=n-a></a>Anaissie J, Roberts NH, Wang P, <i> et al.</i>: Testosterone Replacement Therapy and Components of the Metabolic Syndrome. <i>Sex Med Rev.</i> 2017; <b>5</b>(2): 200210. <a target=xrefwindow id=d15997e2304 href="http://www.ncbi.nlm.nih.gov/pubmed/28202344">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2307 href="https://doi.org/10.1016/j.sxmr.2017.01.003">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d15997e2316 class=n-a></a>Araujo AB, O'Donnell AB, Brambilla DJ, <i> et al.</i>: Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. <i>J Clin Endocrinol Metab.</i> 2004; <b>89</b>(12): 59205926. <a target=xrefwindow id=d15997e2327 href="http://www.ncbi.nlm.nih.gov/pubmed/15579737">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2330 href="https://doi.org/10.1210/jc.2003-031719">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1091822"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e2339 class=n-a></a>Araujo AB, Esche GR, Kupelian V, <i> et al.</i>: Prevalence of symptomatic androgen deficiency in men. <i>J Clin Endocrinol Metab.</i> 2007; <b>92</b>(11): 42414247. <a target=xrefwindow id=d15997e2350 href="http://www.ncbi.nlm.nih.gov/pubmed/17698901">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2353 href="https://doi.org/10.1210/jc.2007-1245">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1091822">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d15997e2366 class=n-a></a>Wang C, Nieschlag E, Swerdloff R, <i> et al.</i>: Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. <i>Eur J Endocrinol.</i> 2008; <b>159</b>(5): 507514. <a target=xrefwindow id=d15997e2377 href="http://www.ncbi.nlm.nih.gov/pubmed/18955511">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2380 href="https://doi.org/10.1530/EJE-08-0601">Publisher Full Text </a> | <a target=xrefwindow id=d15997e2384 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2754376">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d15997e2394 class=n-a></a>Corona G, Rastrelli G, Maseroli E, <i> et al.</i>: Sexual function of the ageing male. <i>Best Pract Res Clin Endocrinol Metab.</i> 2013; <b>27</b>(4): 581601. <a target=xrefwindow id=d15997e2405 href="http://www.ncbi.nlm.nih.gov/pubmed/24054932">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2408 href="https://doi.org/10.1016/j.beem.2013.05.007">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d15997e2417 class=n-a></a>Boloa ER, Uraga MV, Haddad RM, <i> et al.</i>: Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. <i>Mayo Clin Proc.</i> 2007; <b>82</b>(1): 2028. <a target=xrefwindow id=d15997e2428 href="http://www.ncbi.nlm.nih.gov/pubmed/17285782">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2431 href="https://doi.org/10.4065/82.1.20">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d15997e2440 class=n-a></a>Isidori AM, Giannetta E, Gianfrilli D, <i> et al.</i>: Effects of testosterone on sexual function in men: results of a meta-analysis. <i>Clin Endocrinol (Oxf).</i> 2005; <b>63</b>(4): 381394. <a target=xrefwindow id=d15997e2451 href="http://www.ncbi.nlm.nih.gov/pubmed/16181230">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2454 href="https://doi.org/10.1111/j.1365-2265.2005.02350.x">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d15997e2463 class=n-a></a>Corona G, Isidori AM, Buvat J, <i> et al.</i>: Testosterone supplementation and sexual function: a meta-analysis study. <i>J Sex Med.</i> 2014; <b>11</b>(6): 15771592. <a target=xrefwindow id=d15997e2474 href="http://www.ncbi.nlm.nih.gov/pubmed/24697970">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2477 href="https://doi.org/10.1111/jsm.12536">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727547852"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e2486 class=n-a></a>Corona G, Rastrelli G, Morgentaler A, <i> et al.</i>: Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. <i>Eur Urol.</i> 2017; <b>72</b>(6): 10001011. <a target=xrefwindow id=d15997e2497 href="http://www.ncbi.nlm.nih.gov/pubmed/28434676">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2500 href="https://doi.org/10.1016/j.eururo.2017.03.032">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727547852">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726764636"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e2513 class=n-a></a>Huo S, Scialli AR, McGarvey S, <i> et al.</i>: Treatment of Men for Low Testosterone: A Systematic Review. <i>PLoS One.</i> 2016; <b>11</b>(9): e0162480. <a target=xrefwindow id=d15997e2524 href="http://www.ncbi.nlm.nih.gov/pubmed/27655114">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2527 href="https://doi.org/10.1371/journal.pone.0162480">Publisher Full Text </a> | <a target=xrefwindow id=d15997e2531 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5031462">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726764636">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d15997e2545 class=n-a></a>Tsertsvadze A, Fink HA, Yazdi F, <i> et al.</i>: Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis. <i>Ann Intern Med.</i> 2009; <b>151</b>(9): 65061. <a target=xrefwindow id=d15997e2556 href="http://www.ncbi.nlm.nih.gov/pubmed/19884626">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2559 href="https://doi.org/10.7326/0003-4819-151-9-200911030-00150">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d15997e2568 class=n-a></a>Jain P, Rademaker AW, McVary KT: Testosterone supplementation for erectile dysfunction: results of a meta-analysis. <i>J Urol.</i> 2000; <b>164</b>(2): 3715. <a target=xrefwindow id=d15997e2576 href="http://www.ncbi.nlm.nih.gov/pubmed/10893588">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2579 href="https://doi.org/10.1016/S0022-5347(05)67363-6">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d15997e2588 class=n-a></a>Sansone A, Romanelli F, Gianfrilli D, <i> et al.</i>: Endocrine evaluation of erectile dysfunction. <i>Endocrine.</i> 2014; <b>46</b>(3): 423430. <a target=xrefwindow id=d15997e2599 href="http://www.ncbi.nlm.nih.gov/pubmed/24705931">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2602 href="https://doi.org/10.1007/s12020-014-0254-6">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731791457"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e2611 class=n-a></a>Livingston M, Kalansooriya A, Hartland AJ, <i> et al.</i>: Serum testosterone levels in male hypogonadism: Why and when to check-A review. <i>Int J Clin Pract.</i> 2017; <b>71</b>(11): e12995. <a target=xrefwindow id=d15997e2622 href="http://www.ncbi.nlm.nih.gov/pubmed/28980739">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2625 href="https://doi.org/10.1111/ijcp.12995">Publisher Full Text </a> | <a target=xrefwindow id=d15997e2629 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5698762">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731791457">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d15997e2642 class=n-a></a>Caronia LM, Dwyer AA, Hayden D, <i> et al.</i>: Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism. <i>Clin Endocrinol (Oxf).</i> 2013; <b>78</b>(2): 291296. <a target=xrefwindow id=d15997e2653 href="http://www.ncbi.nlm.nih.gov/pubmed/22804876">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2656 href="https://doi.org/10.1111/j.1365-2265.2012.04486.x">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d15997e2665 class=n-a></a>Swerdloff RS, Wang C, Cunningham G, <i> et al.</i>: Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. <i>J Clin Endocrinol Metab.</i> 2000; <b>85</b>(12): 45004510. <a target=xrefwindow id=d15997e2676 href="http://www.ncbi.nlm.nih.gov/pubmed/11134099">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2679 href="https://doi.org/10.1210/jcem.85.12.7045">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d15997e2689 class=n-a></a>Wang C, Catlin DH, Demers LM, <i> et al.</i>: Measurement of Total Serum Testosterone in Adult Men: Comparison of Current Laboratory Methods <i>Versus</i> Liquid Chromatography-Tandem Mass Spectrometry. <i>J Clin Endocrinol Metab.</i> 2004; <b>89</b>(2): 534543. <a target=xrefwindow id=d15997e2703 href="http://www.ncbi.nlm.nih.gov/pubmed/14764758">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2707 href="https://doi.org/10.1210/jc.2003-031287">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d15997e2716 class=n-a></a>Huhtaniemi IT, Tajar A, Lee DM, <i> et al.</i>: Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. <i>Eur J Endocrinol.</i> 2012; <b>166</b>(6): 983991. <a target=xrefwindow id=d15997e2727 href="http://www.ncbi.nlm.nih.gov/pubmed/22423144">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2730 href="https://doi.org/10.1530/EJE-11-1051">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d15997e2739 class=n-a></a>Morales A, Spevack M, Emerson L, <i> et al.</i>: Adding to the controversy: Pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. <i>Aging Male.</i> 2007; <b>10</b>(2): 5765. <a target=xrefwindow id=d15997e2750 href="http://www.ncbi.nlm.nih.gov/pubmed/17558969">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2753 href="https://doi.org/10.1080/13685530701342686">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d15997e2762 class=n-a></a>Tancredi A, Reginster JY, Schleich F, <i> et al.</i>: Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. <i>Eur J Endocrinol.</i> 2004; <b>151</b>(3): 35560. <a target=xrefwindow id=d15997e2773 href="http://www.ncbi.nlm.nih.gov/pubmed/15362965">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2776 href="https://doi.org/10.1530/eje.0.1510355">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d15997e2785 class=n-a></a>Corona G, Mannucci E, Petrone L, <i> et al.</i>: ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. <i>J Sex Med.</i> 2006; <b>3</b>(4): 706715. <a target=xrefwindow id=d15997e2796 href="http://www.ncbi.nlm.nih.gov/pubmed/16839327">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2799 href="https://doi.org/10.1111/j.1743-6109.2006.00262.x">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d15997e2808 class=n-a></a>Camacho EM, Huhtaniemi IT, O'Neill TW, <i> et al.</i>: Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. <i>Eur J Endocrinol.</i> 2013; <b>168</b>(3): 445455. <a target=xrefwindow id=d15997e2819 href="http://www.ncbi.nlm.nih.gov/pubmed/23425925">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2822 href="https://doi.org/10.1530/EJE-12-0890">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d15997e2832 class=n-a></a>Wittert G: The relationship between sleep disorders and testosterone in men. <i>Asian J Androl.</i> 2014; <b>16</b>(2): 2625. <a target=xrefwindow id=d15997e2840 href="http://www.ncbi.nlm.nih.gov/pubmed/24435056">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2843 href="https://doi.org/10.4103/1008-682X.122586">Publisher Full Text </a> | <a target=xrefwindow id=d15997e2846 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3955336">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d15997e2855 class=n-a></a>Santamaria JD, Prior JC, Fleetham JA: Reversible reproductive dysfunction in men with obstructive sleep apnoea. <i>Clin Endocrinol (Oxf).</i> 1988; <b>28</b>(5): 461470. <a target=xrefwindow id=d15997e2863 href="http://www.ncbi.nlm.nih.gov/pubmed/3145819">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2866 href="https://doi.org/10.1111/j.1365-2265.1988.tb03680.x">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d15997e2875 class=n-a></a>Grunstein RR, Handelsman DJ, Lawrence SJ, <i> et al.</i>: Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. <i>J Clin Endocrinol Metab.</i> 1989; <b>68</b>(2): 352358. <a target=xrefwindow id=d15997e2886 href="http://www.ncbi.nlm.nih.gov/pubmed/2493027">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2889 href="https://doi.org/10.1210/jcem-68-2-352">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d15997e2898 class=n-a></a>Schmid SM, Hallschmid M, Jauch-Chara K, <i> et al.</i>: Sleep timing may modulate the effect of sleep loss on testosterone. <i>Clin Endocrinol (Oxf).</i> 2012; <b>77</b>(5): 749754. <a target=xrefwindow id=d15997e2909 href="http://www.ncbi.nlm.nih.gov/pubmed/22568763">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2912 href="https://doi.org/10.1111/j.1365-2265.2012.04419.x">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717964268"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e2921 class=n-a></a>Spitzer M, Basaria S, Travison TG, <i> et al.</i>: Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. <i>Ann Intern Med.</i> 2012; <b>157</b>(10): 68191. <a target=xrefwindow id=d15997e2932 href="http://www.ncbi.nlm.nih.gov/pubmed/23165659">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2935 href="https://doi.org/10.7326/0003-4819-157-10-201211200-00004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717964268">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d15997e2948 class=n-a></a>Spitzer M, Bhasin S, Travison TG, <i> et al.</i>: Sildenafil increases serum testosterone levels by a direct action on the testes. <i>Andrology.</i> 2013; <b>1</b>(6): 913918. <a target=xrefwindow id=d15997e2959 href="http://www.ncbi.nlm.nih.gov/pubmed/24106072">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2962 href="https://doi.org/10.1111/j.2047-2927.2013.00131.x">Publisher Full Text </a> | <a target=xrefwindow id=d15997e2966 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6036338">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726182374"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e2976 class=n-a></a>McBride JA, Coward RM: Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use. <i>Asian J Androl.</i> 2016; <b>18</b>(3): 37380. <a target=xrefwindow id=d15997e2984 href="http://www.ncbi.nlm.nih.gov/pubmed/26908067">PubMed Abstract </a> | <a target=xrefwindow id=d15997e2987 href="https://doi.org/10.4103/1008-682X.173938">Publisher Full Text </a> | <a target=xrefwindow id=d15997e2990 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4854084">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726182374">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d15997e3003 class=n-a></a>Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. <i>Lancet.</i> 1990; <b>336</b>(8721): 9559. <a target=xrefwindow id=d15997e3011 href="http://www.ncbi.nlm.nih.gov/pubmed/1977002">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3014 href="https://doi.org/10.1016/0140-6736(90)92416-F">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d15997e3023 class=n-a></a>Liu PY, Swerdloff RS, Christenson PD, <i> et al.</i>: Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. <i>Lancet.</i> 2006; <b>367</b>(9520): 14121420. <a target=xrefwindow id=d15997e3034 href="http://www.ncbi.nlm.nih.gov/pubmed/16650651">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3037 href="https://doi.org/10.1016/S0140-6736(06)68614-5">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d15997e3046 class=n-a></a>Ly LP, Liu PY, Handelsman DJ: Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens. <i>Hum Reprod.</i> 2005; <b>20</b>(6): 17331740. <a target=xrefwindow id=d15997e3054 href="http://www.ncbi.nlm.nih.gov/pubmed/15860500">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3057 href="https://doi.org/10.1093/humrep/deh834">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735091493"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3066 class=n-a></a>Lee JA, Ramasamy R: Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. <i>Transl Androl Urol.</i> 2018; <b>7</b>(Suppl 3): S348S352. <a target=xrefwindow id=d15997e3074 href="http://www.ncbi.nlm.nih.gov/pubmed/30159241">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3077 href="https://doi.org/10.21037/tau.2018.04.11">Publisher Full Text </a> | <a target=xrefwindow id=d15997e3080 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6087849">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735091493">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d15997e3093 class=n-a></a>Vicari E, Mongio A, Calogero AE, <i> et al.</i>: Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up. <i>Int J Androl.</i> 1992; <b>15</b>(4): 3209. <a target=xrefwindow id=d15997e3104 href="http://www.ncbi.nlm.nih.gov/pubmed/1516981">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3107 href="https://doi.org/10.1111/j.1365-2605.1992.tb01131.x">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d15997e3117 class=n-a></a>Hsieh TC, Pastuszak AW, Hwang K, <i> et al.</i>: Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. <i>J Urol.</i> 2013; <b>189</b>(2): 647650. <a target=xrefwindow id=d15997e3128 href="http://www.ncbi.nlm.nih.gov/pubmed/23260550">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3131 href="https://doi.org/10.1016/j.juro.2012.09.043">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d15997e3140 class=n-a></a>Coviello AD, Matsumoto AM, Bremner WJ, <i> et al.</i>: Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. <i>J Clin Endocrinol Metab.</i> 2005; <b>90</b>(5): 25952602. <a target=xrefwindow id=d15997e3151 href="http://www.ncbi.nlm.nih.gov/pubmed/15713727">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3154 href="https://doi.org/10.1210/jc.2004-0802">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d15997e3163 class=n-a></a>Chua ME, Escusa KG, Luna S, <i> et al.</i>: Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis. <i>Andrology.</i> 2013; <b>1</b>(5): 749757. <a target=xrefwindow id=d15997e3174 href="http://www.ncbi.nlm.nih.gov/pubmed/23970453">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3177 href="https://doi.org/10.1111/j.2047-2927.2013.00107.x">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d15997e3186 class=n-a></a>Moskovic DJ, Katz DJ, Akhavan A, <i> et al.</i>: Clomiphene citrate is safe and effective for long-term management of hypogonadism. <i>BJU Int.</i> 2012; <b>110</b>(10): 15241528. <a target=xrefwindow id=d15997e3197 href="http://www.ncbi.nlm.nih.gov/pubmed/22458540">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3200 href="https://doi.org/10.1111/j.1464-410X.2012.10968.x">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733261483"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3209 class=n-a></a>Soares AH, Horie NC, Chiang LAP, <i> et al.</i>: Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study. <i>Int J Obes (Lond).</i> 2018; <b>42</b>(5): 953963. <a target=xrefwindow id=d15997e3220 href="http://www.ncbi.nlm.nih.gov/pubmed/29777228">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3223 href="https://doi.org/10.1038/s41366-018-0105-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733261483">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727820813"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3236 class=n-a></a>Dadhich P, Ramasamy R, Scovell J, <i> et al.</i>: Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men. <i>Indian J Urol.</i> 2017; <b>33</b>(3): 236240. <a target=xrefwindow id=d15997e3247 href="http://www.ncbi.nlm.nih.gov/pubmed/28717276">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3250 href="https://doi.org/10.4103/iju.IJU_372_16">Publisher Full Text </a> | <a target=xrefwindow id=d15997e3254 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5508437">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727820813">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717995568"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3268 class=n-a></a>Kaminetsky J, Werner M, Fontenot G, <i> et al.</i>: Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. <i>J Sex Med.</i> 2013; <b>10</b>(6): 162835. <a target=xrefwindow id=d15997e3279 href="http://www.ncbi.nlm.nih.gov/pubmed/23530575">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3282 href="https://doi.org/10.1111/jsm.12116">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717995568">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735091538"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3295 class=n-a></a>Lo EM, Rodriguez KM, Pastuszak AW, <i> et al.</i>: Alternatives to Testosterone Therapy: A Review. <i>Sex Med Rev.</i> 2018; <b>6</b>(1): 106113. <a target=xrefwindow id=d15997e3306 href="http://www.ncbi.nlm.nih.gov/pubmed/29174957">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3309 href="https://doi.org/10.1016/j.sxmr.2017.09.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735091538">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d15997e3322 class=n-a></a>Leder BZ, Rohrer JL, Rubin SD, <i> et al.</i>: Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. <i>J Clin Endocrinol Metab.</i> 2004; <b>89</b>(3): 11741180. <a target=xrefwindow id=d15997e3333 href="http://www.ncbi.nlm.nih.gov/pubmed/15001605">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3336 href="https://doi.org/10.1210/jc.2003-031467">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d15997e3345 class=n-a></a>Gan EH, Pattman S, H S Pearce S, <i> et al.</i>: A UK epidemic of testosterone prescribing, 2001-2010. <i>Clin Endocrinol (Oxf).</i> 2013; <b>79</b>(4): 564570. <a target=xrefwindow id=d15997e3356 href="http://www.ncbi.nlm.nih.gov/pubmed/23480258">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3359 href="https://doi.org/10.1111/cen.12178">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d15997e3368 class=n-a></a>Nguyen CP, Hirsch MS, Moeny D, <i> et al.</i>: Testosterone and Age-Related Hypogonadism--FDA Concerns. <i>N Engl J Med.</i> 2015; <b>373</b>(8): 689691. <a target=xrefwindow id=d15997e3379 href="http://www.ncbi.nlm.nih.gov/pubmed/26287846">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3382 href="https://doi.org/10.1056/NEJMp1506632">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732532551"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3391 class=n-a></a>Corona G, Rastrelli G, Reisman Y, <i> et al.</i>: The safety of available treatments of male hypogonadism in organic and functional hypogonadism. <i>Expert Opin Drug Saf.</i> 2018; <b>17</b>(3): 277292. <a target=xrefwindow id=d15997e3402 href="http://www.ncbi.nlm.nih.gov/pubmed/29334271">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3405 href="https://doi.org/10.1080/14740338.2018.1424831">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732532551">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727531941"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3419 class=n-a></a>Busnelli A, Somigliana E, Vercellini P: 'Forever Young'-Testosterone replacement therapy: a blockbuster drug despite flabby evidence and broken promises. <i>Hum Reprod.</i> 2017; <b>32</b>(4): 16. <a target=xrefwindow id=d15997e3427 href="http://www.ncbi.nlm.nih.gov/pubmed/28333214">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3430 href="https://doi.org/10.1093/humrep/dex032">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727531941">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733615091"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3443 class=n-a></a>Bandari J, Ayyash OM, Emery SL, <i> et al.</i>: Marketing and Testosterone Treatment in the USA: A Systematic Review. <i>Eur Urol Focus.</i> 2017; <b>3</b>(45): 395402. <a target=xrefwindow id=d15997e3454 href="http://www.ncbi.nlm.nih.gov/pubmed/29174614">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3457 href="https://doi.org/10.1016/j.euf.2017.10.016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733615091">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d15997e3470 class=n-a></a>Seftel AD: Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke. <i>J Urol.</i> 2015; <b>194</b>(3): 759760. <a target=xrefwindow id=d15997e3478 href="http://www.ncbi.nlm.nih.gov/pubmed/26292880">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3481 href="https://doi.org/10.1016/j.juro.2015.06.058">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d15997e3490 class=n-a></a>Morelli A, Sarchielli E, Comeglio P, <i> et al.</i>: Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. <i>Mol Cell Endocrinol.</i> 2014; <b>382</b>(1): 107119. <a target=xrefwindow id=d15997e3501 href="http://www.ncbi.nlm.nih.gov/pubmed/24064031">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3504 href="https://doi.org/10.1016/j.mce.2013.09.017">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732878989"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3513 class=n-a></a>Bhasin S, Brito JP, Cunningham GR, <i> et al.</i>: Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. <i>J Clin Endocrinol Metab.</i> 2018; <b>103</b>(5): 17151744. <a target=xrefwindow id=d15997e3524 href="http://www.ncbi.nlm.nih.gov/pubmed/29562364">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3527 href="https://doi.org/10.1210/jc.2018-00229">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732878989">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d15997e3540 class=n-a></a>Huggins C, Hodges CV: Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. <i>CA Cancer J Clin.</i> 1972; <b>22</b>(4): 23240. <a target=xrefwindow id=d15997e3548 href="http://www.ncbi.nlm.nih.gov/pubmed/4625049">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3551 href="https://doi.org/10.3322/canjclin.22.4.232">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1050553"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3561 class=n-a></a>Marks LS, Mazer NA, Mostaghel E, <i> et al.</i>: Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. <i>JAMA.</i> 2006; <b>296</b>(19): 235161. <a target=xrefwindow id=d15997e3572 href="http://www.ncbi.nlm.nih.gov/pubmed/17105798">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3575 href="https://doi.org/10.1001/jama.296.19.2351">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1050553">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d15997e3588 class=n-a></a>Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, <i> et al.</i>: Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. <i>J Natl Cancer Inst.</i> 2008; <b>100</b>(3): 170183. <a target=xrefwindow id=d15997e3599 href="http://www.ncbi.nlm.nih.gov/pubmed/18230794">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3602 href="https://doi.org/10.1093/jnci/djm323">Publisher Full Text </a> | <a target=xrefwindow id=d15997e3606 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6126902">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d15997e3615 class=n-a></a>Morgentaler A, Traish AM: Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. <i>Eur Urol.</i> 2009; <b>55</b>(2): 310320. <a target=xrefwindow id=d15997e3623 href="http://www.ncbi.nlm.nih.gov/pubmed/18838208">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3626 href="https://doi.org/10.1016/j.eururo.2008.09.024">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d15997e3635 class=n-a></a>Leibowitz RL, Dorff TB, Tucker S, <i> et al.</i>: Testosterone replacement in prostate cancer survivors with hypogonadal symptoms. <i>BJU Int.</i> 2010; <b>105</b>(10): 13971401. <a target=xrefwindow id=d15997e3646 href="http://www.ncbi.nlm.nih.gov/pubmed/19912179">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3649 href="https://doi.org/10.1111/j.1464-410X.2009.08980.x">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d15997e3658 class=n-a></a>Khera M, Grober ED, Najari B, <i> et al.</i>: Testosterone replacement therapy following radical prostatectomy. <i>J Sex Med.</i> 2009; <b>6</b>(4): 11651170. <a target=xrefwindow id=d15997e3669 href="http://www.ncbi.nlm.nih.gov/pubmed/19207277">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3672 href="https://doi.org/10.1111/j.1743-6109.2009.01161.x">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727802981"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15997e3681 class=n-a></a>Kacker R, Hult M, San Francisco IF, <i> et al.</i>: Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results. <i>Asian J Androl.</i> 2016; <b>18</b>(1): 1620. <a target=xrefwindow id=d15997e3692 href="http://www.ncbi.nlm.nih.gov/pubmed/26306850">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3695 href="https://doi.org/10.4103/1008-682X.160270">Publisher Full Text </a> | <a target=xrefwindow id=d15997e3699 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4736350">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727802981">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d15997e3713 class=n-a></a>Fernndez-Balsells MM, Murad MH, Lane M, <i> et al.</i>: Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. <i>J Clin Endocrinol Metab.</i> 2010; <b>95</b>(6): 25602575. <a target=xrefwindow id=d15997e3724 href="http://www.ncbi.nlm.nih.gov/pubmed/20525906">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3727 href="https://doi.org/10.1210/jc.2009-2575">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d15997e3736 class=n-a></a>Alexander GC, Iyer G, Lucas E, <i> et al.</i>: Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis. <i>Am J Med.</i> 2017; <b>130</b>(3): 293305. <a target=xrefwindow id=d15997e3747 href="http://www.ncbi.nlm.nih.gov/pubmed/27751897">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3750 href="https://doi.org/10.1016/j.amjmed.2016.09.017">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d15997e3759 class=n-a></a>Coviello AD, Kaplan B, Lakshman KM, <i> et al.</i>: Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. <i>J Clin Endocrinol Metab.</i> 2008; <b>93</b>(3): 914919. <a target=xrefwindow id=d15997e3770 href="http://www.ncbi.nlm.nih.gov/pubmed/18160461">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3773 href="https://doi.org/10.1210/jc.2007-1692">Publisher Full Text </a> | <a target=xrefwindow id=d15997e3777 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2266950">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d15997e3786 class=n-a></a>Wang C, Swerdloff RS, Iranmanesh A, <i> et al.</i>: Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. <i>J Clin Endocrinol Metab.</i> 2000; <b>85</b>(8): 28392853. <a target=xrefwindow id=d15997e3797 href="http://www.ncbi.nlm.nih.gov/pubmed/10946892">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3800 href="https://doi.org/10.1210/jcem.85.8.6747">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d15997e3809 class=n-a></a>Grech A, Breck J, Heidelbaugh J: Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. <i>Ther Adv drug Saf.</i> 2014; <b>5</b>(5): 190200. <a target=xrefwindow id=d15997e3817 href="http://www.ncbi.nlm.nih.gov/pubmed/25360240">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3820 href="https://doi.org/10.1177/2042098614548680">Publisher Full Text </a> | <a target=xrefwindow id=d15997e3823 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4212439">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d15997e3832 class=n-a></a>Rhoden EL, Morgentaler A: Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring. <i>N Engl J Med.</i> 2004; <b>350</b>(5): 482492. <a target=xrefwindow id=d15997e3840 href="http://www.ncbi.nlm.nih.gov/pubmed/14749457">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3843 href="https://doi.org/10.1056/NEJMra022251">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d15997e3853 class=n-a></a>Jones SD Jr, Dukovac T, Sangkum P, <i> et al.</i>: Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male. <i>Sex Med Rev.</i> 2015; <b>3</b>(2): 101112. <a target=xrefwindow id=d15997e3864 href="http://www.ncbi.nlm.nih.gov/pubmed/27784544">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3867 href="https://doi.org/10.1002/smrj.43">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d15997e3876 class=n-a></a>Schreijer AJ, Reitsma PH, Cannegieter SC: High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander? <i>Haematologica.</i> 2010; <b>95</b>(2): 1824. <a target=xrefwindow id=d15997e3884 href="http://www.ncbi.nlm.nih.gov/pubmed/20139389">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3887 href="https://doi.org/10.3324/haematol.2009.017285">Publisher Full Text </a> | <a target=xrefwindow id=d15997e3890 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2817018">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d15997e3899 class=n-a></a>Masterson T, Molina M, Ibrahim E, <i> et al.</i>: Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an Ongoing Single-center, Investigator-initiated Phase IV Clinical Trial. <i>Eur Urol Focus.</i> 2018; <b>4</b>(3): 333335. <a target=xrefwindow id=d15997e3910 href="http://www.ncbi.nlm.nih.gov/pubmed/30177402">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3913 href="https://doi.org/10.1016/j.euf.2018.08.009">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d15997e3922 class=n-a></a>Male Hypogonadism EAU Guidelines on. 2016. <a target=xrefwindow id=d15997e3924 href="https://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Hypogonadism-2016-1.pdf">Reference Source</a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d15997e3933 class=n-a></a>Dean JD, McMahon CG, Guay AT, <i> et al.</i>: The International Society for Sexual Medicines Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. <i>J Sex Med.</i> 2015; <b>12</b>(8): 16601686. <a target=xrefwindow id=d15997e3944 href="http://www.ncbi.nlm.nih.gov/pubmed/26081680">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3947 href="https://doi.org/10.1111/jsm.12952">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d15997e3956 class=n-a></a>Zitzmann M, Faber S, Nieschlag E: Association of specific symptoms and metabolic risks with serum testosterone in older men. <i>J Clin Endocrinol Metab.</i> 2006; <b>91</b>(11): 43354343. <a target=xrefwindow id=d15997e3964 href="http://www.ncbi.nlm.nih.gov/pubmed/16926258">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3967 href="https://doi.org/10.1210/jc.2006-0401">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d15997e3977 class=n-a></a>Corona G, Mannucci E, Ricca V, <i> et al.</i>: The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. <i>Int J Androl.</i> 2009; <b>32</b>(6): 720728. <a target=xrefwindow id=d15997e3988 href="http://www.ncbi.nlm.nih.gov/pubmed/19226406">PubMed Abstract </a> | <a target=xrefwindow id=d15997e3991 href="https://doi.org/10.1111/j.1365-2605.2009.00952.x">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Mar 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-331&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-331&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK<br/> <sup>2</sup> Section of Investigative Medicine, Department of Medicine, Imperial College London, London, UK<br/> <p> <div class=margin-bottom> Tharu Tharakan <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Saiful Miah <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Channa N. Jayasena <br/> <span>Roles: </span> Supervision, Writing  Review & Editing </div> <div class=margin-bottom> Suks Minhas <br/> <span>Roles: </span> Conceptualization, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-331/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 25 Mar 2019, 8:331 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.16561.1">https://doi.org/10.12688/f1000research.16561.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2019 Tharakan T <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=18100 data-id=16561 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16561.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-331/v1/pdf?article_uuid=84ecdf91-c3c3-480e-b135-9387b19ae226" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.16561.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Tharakan T, Miah S, Jayasena CN and Minhas S. Investigating the basis of sexual dysfunction during late-onset hypogonadism [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):331 (<a href="https://doi.org/10.12688/f1000research.16561.1" target=_blank>https://doi.org/10.12688/f1000research.16561.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=16561 id=mobile-track-article-signin-16561 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16561?target=/articles/8-331"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18100 /> <input name=articleId type=hidden value=16561 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Ranjith Ramasamy</strong>, Department of Urology, University of Miami-Miller School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Premal Patel</strong>, Department of Urology, University of Miami-Miller School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Giovanni Corona</strong>, Endocrinology Unit, Ospedale Maggiore, Medical Department, Azienda AUSL Bologna, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Mar 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-331&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-331&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=47828-45817></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=47832-45818></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-331/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>25 Mar 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ranjith Ramasamy</strong>, Department of Urology, University of Miami-Miller School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Premal Patel</strong>, Department of Urology, University of Miami-Miller School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Giovanni Corona</strong>, Endocrinology Unit, Ospedale Maggiore, Medical Department, Azienda AUSL Bologna, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-331&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-331/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Investigating the basis of sexual dysfunction...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-331/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-331/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-331/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Tharakan T et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-331/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-331",
            templates : {
                twitter : "Investigating the basis of sexual dysfunction during late-onset.... Tharakan T et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-331/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Investigating the basis of sexual dysfunction during late-onset hypogonadism", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Investigating the basis of sexual dysfunction during late-onset hypogonadism", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/16561/18100")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "18100");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "45817": 0,
                           "45818": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "0a2be85f-bc27-44f0-a779-2c4396dc5904";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-331.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-331.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-331.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-331.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-331.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>